ADA Standards Updated With Renal Guidance Based on CREDENCE ADA Standards Updated With Renal Guidance Based on CREDENCE

New renal management guidance is based on data from the recently reported Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy (CREDENCE) trial.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news